Pricing

Log inSign up

Y-mAbs Therapeutics

0 followers

‌

Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.

Industries

Biotechnology

Headquarters

New York, United States

Employees

51-200

Links

Org chart

TG
Thomas Gad
Chairman & CEO

Thomas Gad

Collapse
Vignesh Rajah
SVP & CMO
Joris Wilms
SVP & COO
SS
Sue Smith
SVP & Chief Commercial Officer
Christopher Naylor
Senior Director, Head of Human Resources
René Christensen
Vice President Biometrics
RL
Rikke Lillesø
Vice President
SC
Søren Christensen
Director Protein Engineering
SN
Sune Nyland
VP, General Counsel
TS
Tore Søderblom
VP CMC development
Courtney Dugan
Vice President, Head of Investor Relations
Robert Gunning
VP, Finance and Corporate Controller
Peter Pfreundschuh
Chief Financial Officer
CR
Charlotte A. Russell
Senior Medical Director
Karen Tornøe
Senior Medical Director
RT
Ramin T.
Medical Director
Johannes Nagel
Principal Scientist Radiochemistry
Kandarp Jani
Research Associate
LW
Linlin Wang
Principal Scientist
Mallika Vadlamudi, Ph.D.
Research Scientist
John Lapolla
Director, Scientific Communications

Teams

+14

Scientific Research and Development

17 members

+11

Leadership Team

14 members

+5

Sales and Account Management

8 members

+4

Clinical and Medical Operations

7 members

+4

Marketing and Commercial Strategy

7 members

Finance and Accounting

2 members

Similar companies

SpringWorks Therapeutics

5 followers

Inari

1 follower

Entrada Therapeutics

1 follower

Scholar Rock

1 follower

Thermo Fisher Scientific

156 followers

Neurelis

2 followers

GRAIL

27 followers

Cytokinetics

11 followers

Artivion

3 followers

Axsome Therapeutics

2 followers

BridgeBio

2 followers

Explore companies